Core Insights - Picard Medical, Inc. will participate in the inaugural "Hands-On Training Day" at the THT 2026 conference to enhance education on the SynCardia Total Artificial Heart for advanced heart failure patients [1][2] Company Overview - Picard Medical is the parent company of SynCardia Systems, which produces the only commercially available total artificial heart approved by the U.S. FDA and Health Canada [6] - The SynCardia Total Artificial Heart has been implanted over 2,100 times across 27 countries, making it the most widely used artificial heart globally [6] Training Program Details - The training program will feature interactive, case-based learning aimed at improving multidisciplinary collaboration and patient outcomes in advanced heart failure [2][4] - Clinicians will engage with the technology through hands-on training, focusing on real-world clinical scenarios [3][4] - Senior Clinical Specialists will lead the training, providing direct interaction with the Companion 2 Driver, Freedom Portable Driver, and the SynCardia Total Artificial Heart [3] Conference Information - The THT 2026 conference focuses on advancing heart failure innovation through emerging devices and therapies, bringing together clinicians, researchers, and industry partners [5] - The program includes scientific sessions, case discussions, and hands-on training to foster collaboration and improve patient outcomes [5]